Intervention

Blood Test

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials5

Recruiting0

Common conditions9

Lead sponsors shown5

Clinical trials

5 shown

Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related DementiasNCT04786223 · 2021-03-30

ENROLLING_BY_INVITATION

CT-Based Modeling of Bone Micro-Architecture and Fracture-Risk in COPDNCT03534934 · 2019-02-26

COMPLETED

Endothelial Function in Patients With Pulmonary Arterial HypertensionNCT01317134 · 2010-10-01

COMPLETED

Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer PatientsNCT00806507 · 2008-11-01

COMPLETED

Evaluation of Clinical Significance of Circulating Markers in Breast Cancer Patients Undergoing Herceptin TherapyNCT00530569 · 2007-08-01

UNKNOWN

Common conditions

Breast Cancer2 Alzheimer Dementia (AD)1 Genetics1 Hypertension, Pulmonary1 Lewy Body Dementia (LBD)1 Osteoporosis1 Pathophysiology1 Pulmonary Arterial Hypertension1 Pulmonary Disease, Chronic Obstructive1

Leading sponsors

Alberta Health services 1 M.D. Anderson Cancer Center 1 Punam K Saha 1 Universitätsklinikum Hamburg-Eppendorf 1 Val Lowe 1

Trial status mix

COMPLETED3

ENROLLING_BY_INVITATION1

UNKNOWN1

Phase mix

NA2

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.